NPI 1487661831 — Billing Profile & Reimbursement Data
NPI 1487661831 · XX · healthcare
Customize your policy alerts
Sign up for NPI 1487661831 — Billing Profile & Reimbursement Data policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
NPI 1487661831 is a healthcare provider located in Unspecified Location. This profile covers 63 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services. Note: "XX" is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; claims coded under it are grouped and benchmarked here the same way a traditional state would be.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | NPI 1487661831 |
| Address | |
| City | |
| State | XX (Unspecified Location) |
| ZIP | |
| Taxonomy | N/A |
| NPI Enumerated | |
| NPI Deactivated | October 2, 2024 |
(source: CMS Medicare & Medicaid claims data)
Medicare: Total Revenue Breakdown by CPT/HCPCS Code
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
Medicare: Complete Services Breakdown
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
63 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 1,620 | $140 | $224.6K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 2,760 | $30 | $93.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,660 | $60 | $93K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 1,280 | $70 | $88.2K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 540 | $140 | $72.6K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 1,380 | $30 | $46.9K |
| 87516 | The lab analyst performs a test for hepatitis B virus using amplified nucleic acid probe technique. Hepatitis B virus (HBV) may cause acute or chronic liver disease. | 610 | $30 | $20.7K |
| 87521 | A lab tests a patient’s specimen to provide a definitive diagnosis of hepatitis C by amplified probe technique. | 590 | $30 | $20K |
| 87641 | The lab analyst performs a test for methicillin–resistant Staphylococcus aureus (MRSA) using an amplified nucleic acid probe technique. | 520 | $30 | $17.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 310 | $50 | $16.5K |
Showing 1–10 of 63
Medicare: Competitive Analysis & Benchmarks
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 63 CPT/HCPCS codes. Note: this provider's state, "XX," is a placeholder CMS uses when a provider's practice-location state wasn't reported — not a traditional US state; the State panel below benchmarks against other providers coded under the same designation.
View: State1 / 2
Full comparison — all codes billed, vs. state median
63 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0439 | 25 | 10 | 160 | $130 | $20.5K |
| 99213 | 1,846 | 10 | 140 | $60 | $18.8K |
| 99214 | 123 | 10 | 80 | $90 | $15.8K |
| 99215 | 993 | 10 | 60 | $110 | $13.3K |
| 99203 | 3,172 | 10 | 140 | $90 | $12.2K |
| 99496 | 64 | 10 | 60 | $180 | $10.4K |
| 99490 | 110 | 10 | 160 | $40 | $6.3K |
| 85025 | 60 | 10 | 820 | $10 | $6.2K |
| 36415 | 70 | 10 | 230 | $10 | $5.5K |
| 99495 | 197 | 10 | 30 | $140 | $4.4K |
Showing 1–10 of 63
Frequently Asked Questions
References
- 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
- 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.